Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegcetacoplan PFS in Geographic Atrophy
NCT07214740Phase 3Completed
- Sponsor
- Apellis Pharmaceuticals
- Start
- Oct 2025
- Primary completion
- Dec 2025
- Modality
- PEGylated Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of pegcetacoplan, sponsored by Apellis Pharmaceuticals. Started Oct 2025; status: completed.
02
Drugs
pegcetacoplan
Beyond the preview
Go deeper on NCT07214740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07214740.